Stem Cell News

BioInformant's coverage of stem cell news includes iPS cells, mesenchymal stem cells, hematopoietic stem cells, neural stem cells and more.

As the first and only market research firm to specialize in stem cell news, BioInformant research has been cited by the Wall Street Journal, Xconomy, AABB, and Vogue Magazine.

Serving Fortune 500 leaders that include GE Healthcare, Pfizer, and Goldman Sachs, BioInformant is your global leader in stem cell industry news.

The American Academy of Stem Cell Physicians Adds Three Workshops to the June 17-19, 2022 Conference

May 16, 2022 By Cade Hildreth (CEO) Leave a Comment

The hands-on work shops will be on Intradiscal Injections, Bone Marrow Aspiration, and Musculoskeletal Ultrasound techniques.

MIAMI, May 17, 2022 – The American Academy of Stem Cell Physicians has added three new workshops to its long awaited conference this June 17-19, 2022. The hands-on workshops will be led by industry leaders from across the regenerative medicine field. The workshops will be on Intradiscal Injections, Bone Marrow Aspiration, and Musculoskeletal UltraSound techniques. Beyond these educational workshops, the American Academy of Stem Cell is presenting a lineup of acclaimed regenerative medicine leaders in their field discussing what’s new in regenerative medicine. This conference is not to be missed! [Read more…]

PolarityTE Announces FDA RMAT Awarded to Its Designation Granted to SkinTE®

May 16, 2022 By Cade Hildreth (CEO) 1 Comment

SALT LAKE CITY, May 13, 2022 –PolarityTE, Inc. (Nasdaq: PTE) today announced that the U.S. Food and Drug Administration (FDA) granted a Regenerative Medicine Advanced Therapy (RMAT) designation to SkinTE under the Company’s open IND. [Read more…]

denovoMATRIX Launches Novel Microcarrier to Advance Cell and Gene Therapy Manufacturing

May 4, 2022 By Cade Hildreth (CEO) Leave a Comment

DRESDEN, Germany, May. 04, 2022 — denovoMATRIX GmbH, an innovator in cell and gene therapy (CGT) manufacturing, announced the launch of a novel microcarrier for increasing access to high-quality mesenchymal stromal cells (MSCs) for stem cell-based therapies. The product, termed beadMATRIX, is designed to enable MSC proliferation and harvest in xeno-/serum-free media with high efficiency and stemness.

[Read more…]

Distinguished Physician, Dr. Warren J. Bleiweiss, Fellow of the AASCP, Will Present at the AASCP Conference on June 17-19, 2022

May 1, 2022 By Cade Hildreth (CEO) 1 Comment

American Academy of Stem Cell Physicians will host expert speakers from across the country lecturing on recent innovations in stem cell research on June 17-19, 2022, in Miami, Florida.

“The Academy is proud to offer state-of-the-art Regenerative Medicine workshops this June, which will be lead by experts with over 100 years of combined experience,” said Dr. Sunny Kim, President of the AASCP. [Read more…]

Interview with Uri Lee, CEO of Xcell Therapeutics

April 29, 2022 By Cade Hildreth (CEO) Leave a Comment

This is an interview with Uri Lee, CEO of Xcell Therapeutics. Xcell is an international leader in serum-free, chemically defined media. In this interview, we discuss the mission and purpose of Xcell Therapeutics, its product development pipeline, its rapid growth, and the company’s future goals. Enjoy. [Read more…]